Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Out of harm's way

Nature Biotechnology volume 29, pages 41–42 (2011)Cite this article

Subjects

Screening for safe harbor sites in the genome may improve the safety of gene therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Papapetrou, E.P. et al. Nat. Biotechnol. 29, 73–78 (2011).

    Article  CAS  Google Scholar 

  2. Felice, B. et al. PLoS ONE 4, e4571 (2009).

    Article  Google Scholar 

  3. Cattoglio, C. et al. Blood published online, doi:10.1182/blood-2010–05–283523 (23 September 2010).

  4. Cavazzana-Calvo, M. et al. Nature 467, 318–322 (2010).

    Article  CAS  Google Scholar 

  5. Hockemeyer, D. et al. Nat. Biotechnol. 27, 851–857 (2009).

    Article  CAS  Google Scholar 

  6. Perez, E.E. et al. Nat. Biotechnol. 26, 808–816 (2008).

    Article  CAS  Google Scholar 

  7. DeKelver, R.C. et al. Genome Res. 20, 1133–1142 (2010).

    Article  CAS  Google Scholar 

  8. Henckaerts, E. et al. Proc. Natl. Acad. Sci. USA 106, 7571–7576 (2009).

    Article  CAS  Google Scholar 

  9. Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).

    CAS  Google Scholar 

  10. Hanna, J. et al. Science 318, 1920–1923 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. David A. Williams is at Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.,

    David A Williams

  2. Adrian J. Thrasher is at the Centre for Immunodeficiency, Molecular Immunology Unit, Institute of Child Health, London, UK.,

    Adrian J Thrasher

Authors
  1. David A Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrian J Thrasher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to David A Williams or Adrian J Thrasher.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, D., Thrasher, A. Out of harm's way. Nat Biotechnol 29, 41–42 (2011). https://doi.org/10.1038/nbt.1750

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1750

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research